Why founders hide strain from investors: the disclosure gap.
Founders who keep strain from their board are rarely in denial. They are running a calculation about funding, control and how they will be seen. Martha's review of 318 founders puts numbers on that calculation.
Martha Fernandez, LCSWLead author. Licensed Clinical Social Worker, California license 127918
Clinical review of 318 consecutive founder and venture-backed operator clients, January 2025 to July 2026
Silence is a calculation, not a flaw
A founder's identity is tied to the company, investors hold real power over it, and there is rarely a place to talk that is both confidential and free of evaluation. In that setting, saying nothing looks rational. The paper treats it that way: not as avoidance, but as a risk decision made with the information the founder has.
Outside data points the same way. In Startup Snapshot's 2023 survey of more than 400 founders, 76 percent leaned on a spouse or family for support, 49 percent on a co-founder and 10 percent on an investor, and 81 percent said they were not really open about their stress.
What the review found
- Concealment is the norm. Almost two in three founders in the review actively hid strain from investors or their board.
- The fear is about money and control. 58 percent named funding or professional consequences as the main reason.
- It lasts. Nearly half kept it hidden for more than six months, and the median gap from recognizing the strain to a first session was 21 months.
- Hiding has its own cost. 53 percent said the concealment itself added to the load they were carrying.
A confidential place to think, with no line to the company, the board or the cap table.
Book your first sessionWhat closes the gap
The paper's finding is that telling founders to be more open does not change the math. What changes it is a confidential channel with no line to the company or the cap table: private pay, no diagnosis code sent to an insurer, nothing in company systems. Whether, when and how to tell the board becomes something to work through in session, on the founder's timeline, not a condition of getting help.
For founders in the Bay Area, see therapy in San Francisco or San Jose.
Frequently asked questions
Is 64% true of all founders?
No. It comes from founders who sought care and is self-reported, so it is not an estimate for founders in general.
Does it count only diagnosed conditions?
No. It includes anxiety, exhaustion, low mood and insomnia that founders chose to keep from investors, diagnosed or not.
Will private-pay therapy show up anywhere my company can see?
No. Nothing is billed to insurance or invoiced to a company, so there is no claim and no record in company systems.
Keep reading
Financial District to Pacific Heights. Therapy that never shows up on a company benefit report.
City pageSee San Francisco San JoseSilicon Valley founders and engineers, booked this week, nothing billed to the company plan.
City pageSee San Jose 61%of physicians delayed therapy over licensing or credentialing fears.
Why physicians delay therapyResearch summaryRead the summary